Abbott Laboratories shares slumped Thursday after the drugmaker narrowed its full-year outlook, even as it posted better-than ...

With nearly 4 million coronavirus cases across the United States and hospitalizations surging in different parts of the country, there continues to be a growing demand for COVID-19 tests ...

The national percentage of positive COVID-19 tests increased slightly in the week ending Aug. 29 after declining since mid-July, according to the CDC's weekly COVIDView report.

Abbott Laboratories (ABT) reports robust earnings growth and margin expansion, driven by medical devices, despite headwinds ...

Covid-19 still present, ... COVID-19: A potential wave looms despite decline in cases ... People are just not doing self-testing or getting tested at the doctor’s office like they did during the ...

Moderna MRNA kicked off 2025 with mixed first-quarter results. While its streamlining efforts improved bottom-line numbers, the steep decline in revenues raises concerns.. While sales of its COVID ...

Moderna MRNA kicked off 2025 with mixed first-quarter results. While its streamlining efforts improved bottom-line numbers, the steep decline in revenues raises concerns. While sales of its COVID ...